Bromocriptine for Idiopathic Intracranial Hypertension: A Retrospective Multicenter Cohort Study
Bromocriptine shows promise as an effective and safe therapeutic option for IIH, with sustained improvement in clinical parameters and reduced reliance on conventional treatment. Future randomized controlled trials are needed to confirm these findings and explore optimal dosing strategies.
Authors
- Mohamed D Morsy (ORCID: https://orcid.org/0000-0003-1176-3380)
- David Altschul (ORCID: https://orcid.org/0000-0002-5130-1378)
- Mohammed Tarek Mirdad
- Saif Aboud M. Alqahtani (ORCID: https://orcid.org/0000-0002-9812-6562)
- Hana J Abukhadijah (ORCID: https://orcid.org/0009-0008-7993-7467)
- Mohammed Abadi Alsaleem (ORCID: https://orcid.org/0000-0002-3205-1713)
- Ahmed Y. Azzam (ORCID: https://orcid.org/0000-0002-4256-0159)
- Mahmoud M Morsy (ORCID: https://orcid.org/0009-0001-4356-5306)
- Osman Elamin
Institutions
- Albert Einstein College of Medicine (US)
- Montefiore Medical Center (US)
- Neurological Surgery (US)
- October 6 University (EG)
- Hamad Medical Corporation (QA)
- King Khalid University (SA)
Publication Details
- Journal
- International Journal of General Medicine
- Published
- 2025-04-01
- DOI
- https://doi.org/10.2147/ijgm.s512250
- Primary Topic
- Cerebral Venous Sinus Thrombosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- King Khalid University